Bambusa Therapeutics Shares Fall at Debut After Enlarged US IPO
Bambusa Therapeutics shares fell at their debut after its US IPO was increased in size.
Related stories
Twilio Shares Fall 17.26% Despite Nearly 24% Free-Cash-Flow Margin
Twilio fell 17.25% to $200.16 on October 30. Its growth outlook overshadowed strong cash generation, the report says.
M impact | EQUITY | Oct 30, 2026, 07:32 PM UTC
AMD Shares Fell Nearly 10% Friday as Chip Demand Concerns Grew
AMD shares dropped nearly 10% in Friday morning trading as investors questioned whether chip-industry demand could hold up after a rival’s disappointing outlook. AMD is scheduled t
M impact | EQUITY | Oct 30, 2026, 07:31 PM UTC
US session market picture: S&P 500 -2.13%, Nasdaq 100 -3.87%; EUR/USD -0.09%, WTI +1.43%, INTC leads volume
US session market picture. US index futures: S and P futures is down 2.13 percent, Nasdaq futures is down 3.87 percent, Dow futures is down 1.32 percent and Russell futures is down
M impact | EQUITY | Oct 30, 2026, 07:30 PM UTC
Alphabet Convertible Preferred Yield Tops 7.5%
Alphabet’s mandatory convertible preferred stock, issued as part of its $85 billion equity capital-raising plan in June, has fallen alongside the company’s common stock and now yie
H impact | EQUITY | Oct 30, 2026, 07:25 PM UTC
JioStar Q2 Profit Falls 13% Amid Weak Advertising Environment
Reliance Industries' entertainment subsidiary reported September-quarter revenue up 10% year on year to Rs. 6,806 crore and EBITDA down nearly 14% to Rs. 1,502 crore. Profit after
M impact | EQUITY | Oct 30, 2026, 07:18 PM UTC
Nasdaq Near Session Lows Approaching Close
The Nasdaq remained near session lows approaching the close.
M impact | EQUITY | Oct 30, 2026, 07:16 PM UTC